These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33493286)

  • 1. Durometry in SSc: The hard facts. A systematic literature review and additional pilot study.
    Vanhaecke A; Verschuere S; Vilela V; Heeman L; Cutolo M; Smith V
    Rheumatology (Oxford); 2021 May; 60(5):2099-2108. PubMed ID: 33493286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients.
    Cutolo M; Vanhaecke A; Ruaro B; Deschepper E; Ickinger C; Melsens K; Piette Y; Trombetta AC; De Keyser F; Smith V;
    Autoimmun Rev; 2018 Aug; 17(8):775-780. PubMed ID: 29885540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency ultrasonography: reliable tool to measure skin fibrosis in SSC? A systematic literature review and additional pilot study.
    Vanhaecke A; Cutolo M; Heeman L; Vilela V; Deschepper E; Melsens K; Smith V
    Rheumatology (Oxford); 2021 Dec; 61(1):42-52. PubMed ID: 34037710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durometry for the assessment of skin disease in systemic sclerosis.
    Kissin EY; Schiller AM; Gelbard RB; Anderson JJ; Falanga V; Simms RW; Korn JH; Merkel PA
    Arthritis Rheum; 2006 Aug; 55(4):603-9. PubMed ID: 16874783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durometry as an alternative tool to the modified Rodnan's skin score in the assessment of diffuse systemic sclerosis patients: a cross-sectional study.
    de Oliveira MFC; Leopoldo VC; Pereira KRC; de Moraes DA; Dias JBE; Gonçalves MS; Ramalho LNZ; Dos Santos BN; de Oliveira MC; Silveira RCCP
    Adv Rheumatol; 2020 Sep; 60(1):48. PubMed ID: 32958068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.
    Low AHL; Ng SA; Berrocal V; Brennan B; Chan G; Ng SC; Khanna D
    Int J Rheum Dis; 2019 Jun; 22(6):1036-1040. PubMed ID: 30838791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of myotonometer in the assessment of skin involvement in systemic sclerosis.
    Öztürk Ö; Şahin D; Acar AÖ; Saldiran TÇ; Uzun NN; Şen N; Tezcan ME
    Clin Rheumatol; 2024 Feb; 43(2):695-705. PubMed ID: 38114818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.
    Merkel PA; Silliman NP; Denton CP; Furst DE; Khanna D; Emery P; Hsu VM; Streisand JB; Polisson RP; Akesson A; Coppock J; van den Hoogen F; Herrick A; Mayes MD; Veale D; Seibold JR; Black CM; Korn JH; ;
    Arthritis Rheum; 2008 May; 59(5):699-705. PubMed ID: 18438905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study.
    Van Praet JT; Smith V; Haspeslagh M; Degryse N; Elewaut D; De Keyser F
    Arthritis Res Ther; 2011 Feb; 13(1):R35. PubMed ID: 21356083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-of-the-art technologies provide new insights linking skin and blood vessel abnormalities in SSc-related disorders.
    Dinsdale G; Wilkinson S; Wilkinson J; Moore TL; Manning JB; Berks M; Marjanovic E; Dickinson M; Herrick AL; Murray AK
    Microvasc Res; 2020 Jul; 130():104006. PubMed ID: 32320708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis.
    Corrado A; Colia R; Mele A; Di Bello V; Trotta A; Neve A; Cantatore FP
    PLoS One; 2015; 10(9):e0137912. PubMed ID: 26375284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis.
    Corallo C; Pinto AM; Renieri A; Cheleschi S; Fioravanti A; Cutolo M; Soldano S; Nuti R; Giordano N
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):69-75. PubMed ID: 31365333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
    Corallo C; Cheleschi S; Cutolo M; Soldano S; Fioravanti A; Volpi N; Franci D; Nuti R; Giordano N
    Arthritis Res Ther; 2019 Jun; 21(1):152. PubMed ID: 31234888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database.
    Frantz C; Huscher D; Avouac J; Hachulla E; Balbir-Gurman A; Riemekasten G; Siegert E; Lazzaroni MG; Carreira PE; Vettori S; Zanatta E; Ullman S; Czirjàk L; Kowal-Bielecka O; Distler O; Matucci-Cerinic M; Allanore Y;
    Autoimmun Rev; 2020 Feb; 19(2):102452. PubMed ID: 31838157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin involvement in systemic sclerosis.
    Czirják L; Foeldvari I; Müller-Ladner U
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v44-5. PubMed ID: 18784142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spleen elastography in patients with Systemic sclerosis.
    Karalilova R; Doykova K; Batalov Z; Doykov D; Batalov A
    Rheumatol Int; 2021 Mar; 41(3):633-641. PubMed ID: 33495915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.
    Karalilova R; Kazakova M; Sapundzhieva T; Dichev V; Batalov Z; Sarafian V; Batalov A
    Rheumatol Int; 2019 Nov; 39(11):1841-1848. PubMed ID: 31375891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients.
    Martínez-Godínez MA; Cruz-Domínguez MP; Jara LJ; Domínguez-López A; Jarillo-Luna RA; Vera-Lastra O; Montes-Cortes DH; Campos-Rodríguez R; López-Sánchez DM; Mejía-Barradas CM; Castelán-Chávez EE; Miliar-García A
    Isr Med Assoc J; 2015 Jan; 17(1):5-10. PubMed ID: 25739168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.